CONTRA-MAB Trademark

Trademark Overview


On Thursday, August 16, 2018, a trademark application was filed for CONTRA-MAB with the United States Patent and Trademark Office. The USPTO has given the CONTRA-MAB trademark a serial number of 88081271. The federal status of this trademark filing is REGISTERED as of Tuesday, April 7, 2020. This trademark is owned by INHIBRX, INC.. The CONTRA-MAB trademark is filed in the Pharmaceutical Products category with the following description:

Genetically engineered proteins for diagnostic purposes; gene therapy and proteins, namely, antibodies and fusion proteins for the treatment of cancer; pharmaceutical substances and preparations namely, genetically engineered proteins for medical diagnostic use; pharmaceutical and biochemical preparations for the treatment of cancer; Biochemicals, namely, engineered proteins for the regulation of human, animal, plant, viral and microbial genes for clinical and medical laboratory use in human and animal therapeutics for the treatment of cancer, DNA diagnostics and bioinformatics for medical diagnostic purposes
contra-mab

General Information


Serial Number88081271
Word MarkCONTRA-MAB
Filing DateThursday, August 16, 2018
Status700 - REGISTERED
Status DateTuesday, April 7, 2020
Registration Number6029997
Registration DateTuesday, April 7, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 5, 2019

Trademark Statements


Goods and ServicesGenetically engineered proteins for diagnostic purposes; gene therapy and proteins, namely, antibodies and fusion proteins for the treatment of cancer; pharmaceutical substances and preparations namely, genetically engineered proteins for medical diagnostic use; pharmaceutical and biochemical preparations for the treatment of cancer; Biochemicals, namely, engineered proteins for the regulation of human, animal, plant, viral and microbial genes for clinical and medical laboratory use in human and animal therapeutics for the treatment of cancer, DNA diagnostics and bioinformatics for medical diagnostic purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, August 25, 2018
Primary Code005
First Use Anywhere DateTuesday, September 10, 2019
First Use In Commerce DateTuesday, September 10, 2019

Trademark Owner History


Party NameINHIBRX BIOSCIENCES, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressLA JOLLA, CA 92037

Party NameINHIBRX, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Party NameINHIBRX, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Party NameINHIBRX, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Trademark Events


Event DateEvent Description
Monday, August 20, 2018NEW APPLICATION ENTERED
Saturday, August 25, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 3, 2018ASSIGNED TO EXAMINER
Thursday, December 6, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, December 6, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, December 6, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, December 6, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 6, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 26, 2018ASSIGNED TO LIE
Wednesday, January 16, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 5, 2019PUBLISHED FOR OPPOSITION
Tuesday, February 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 2, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 27, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, August 27, 2019SOU EXTENSION 1 FILED
Tuesday, August 27, 2019SOU EXTENSION 1 GRANTED
Thursday, August 29, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 28, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, January 28, 2020USE AMENDMENT FILED
Wednesday, February 12, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 20, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 3, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 4, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 7, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, June 13, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP